
James R. Gossage MD
Critical Care Medicine, Pleural Disease, Pulmonary Vascular Medicine
Professor, Medicine, Medical College of Georgia at Georgia Health Sciences University
Join to View Full Profile
1499 Walton WaySte 1400Augusta, GA 30901
Phone+1 706-721-4501
Fax+1 706-721-1459
Dr. Gossage is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Vanderbilt University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1991
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1984 - 1987
- Rush Medical College of Rush University Medical CenterClass of 1984
Certifications & Licensure
- GA State Medical License 1994 - 2025
- TN State Medical License 1988 - 1994
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding Start of enrollment: 2006 Oct 01
- Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia Start of enrollment: 2010 Apr 08
- North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Start of enrollment: 2011 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Arteriovenous malformation from a patient with JP-HHT harbours two second-hit somatic DNA alterations in.Evon DeBose-Scarlett, Andrew K Ressler, Cassi Friday, Kara K Prickett, James W Roberts
Journal of Medical Genetics. 2025-03-20 - Brain and lung arteriovenous malformation rescreening practices for children and adults with hereditary hemorrhagic telangiectasia.Lauren A Beslow, Helen Kim, Steven W Hetts, Felix Ratjen, Marianne S Clancy
Orphanet Journal of Rare Diseases. 2024-11-09 - 3 citationsSomatic mutations in arteriovenous malformations in hereditary hemorrhagic telangiectasia support a bi-allelic two-hit mutation mechanism of pathogenesis.Evon DeBose-Scarlett, Andrew K Ressler, Carol J Gallione, Gonzalo Sapisochin Cantis, Cassi Friday
American Journal of Human Genetics. 2024-10-03
Other
- Pulmonary arteriovenous malformations: Diagnostic evaluationGossage JR
http://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-diagnostic-evaluation
UpToDate, Wolters Kluwer Health - 2012-01-16 - Pulmonary arteriovenous malformations: Epidemiology, etiology, pathology, and clinical featuresGossage JR
http://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-patholo
UpToDate, Wolters Kluwer Health - 2012-01-16 - Pulmonary arteriovenous malformations: TreatmentGossage JR
http://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-treatment
UpToDate, Wolters Kluwer Health - 2012-01-16
Grant Support
- A Phase II/III randomized, placebo controlled, double blind study to evaluate the effects of up to 24 weeks of low dose pazopanib on HHT related epistaxis and anemia. IND#144808 June 25, 2020HHT FOUNDATION INTERNATIONAL, INC.2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: